Is nationwide special campaign on antibiotic stewardship program effective on ameliorating irrational antibiotic use in China? Study on the antibiotic use of specialized hospitals in China in 2011-2012

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 34, Issue 3, 2014, Pages 456-463

  Zou, Xiao Xu ^a   Fang, Zi ^b,c   Min, Rui ^a   Bai, Xue ^a   Zhang, Yang ^d   Xu, Dong ^d   Fang, Peng Qian ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY   (China)

^c ROBERT GORDON UNIVERSITY   (United Kingdom)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

antibiotic prescription; antibiotic usage; national antibiotic stewardship program, China; specialized hospital

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; CHINA; CLASSIFICATION; DRUG USE; DRUG UTILIZATION; GEOGRAPHY; HOSPITAL; HOSPITAL PATIENT; HUMAN; METHODOLOGY; OUTPATIENT; PRESCRIPTION; STATISTICS;

ANTI-BACTERIAL AGENTS; CHINA; DRUG PRESCRIPTIONS; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; GEOGRAPHY; HOSPITALS; HUMANS; INPATIENTS; OUTPATIENTS;

EID: 84904013648     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-014-1300-6     Document Type: Article

References (53)

1. Klugman KP, Koornhof HJ. Worldwide increase in pneumococcal antibiotic resistance. Lancet, 1989,2(8660): 444
2. Hawkey PM. Action against antibiotic resistance: no time to lose. Lancet, 1998,351(9112):1298-1299
3. Dong L, Yan H, Wang D. Antibiotic prescribing patterns in village health clinics across 10 provinces of Western China. J Antimicrob Chemother, 2008, 62(2):410-415
4. Ferber D. Antibiotic resistance. Superbugs on the hoof? Science, 2000, 288(5467):792-794
5. Kmietowicz Z. WHO warns of threat of "superbugs". BMJ, 2000, 320(7250):1624
6. le Grand A, Hogerzeil HV, Haaijer-Ruskamp FM. Intervention research in rational use of drugs: a review. Health Policy Plan, 1999, 14(2):89-102
7. Phelps CE. Bug/drug resistance. Sometimes less is more. Med Care, 1989, 27(2):194-203
8. Zhang R, Eggleston K, Rotimi V, et al. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health, 2006, 2:6
9. World Health Organization. The evolving threat of antimicrobial resistance: Options for action. World Health Organization, 2012
10. Tang S, Meng Q, Chen L, et al. Tackling the challenges to health equity in China. Lancet, 2008, 372(9648): 1493-1501
11. Meng Q, Xu L, Zhang Y, et al. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet, 2012, 379(9818):805-814
12. Kondro W. Canadian scientists urge government to develop antibiotic plan. Lancet, 2002, 360(9341):1230
13. de Man P, Verhoeven BA, Verbrugh HA, et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet, 2000, 355(9208):973-978
14. Schito GC, Debbia EA, Marchese A. The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project. J Antimicrob Chemother, 2000, 46(Suppl T1):3-9
15. WHO, Ministry of Health in China. China-WHO Country Cooperation Strategy 2013-2015. World Health Organization, 2013
16. Chen W, Tang S, Sun J, et al. Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces. BMC Health Serv Res, 2010, 10:211
17. Xiang X, Yang C, Wang D, et al. Effects of China's national essential medicines policy on the use of injection in primary health facilities. J Huazhong Univ Sci Technolog Med Sci, 2012, 32(4):626-629
18. Heddini A, Cars O, Qiang S, et al. Antibiotic resistance in China - a major future challenge. Lancet, 2009, 373(9657):30
19. Jing L. China faces great risk due to overuse of antibiotics. 2013. http://www.nationmultimedia.com/opinion/China-faces-great-risk-due-to-overuse- of-antibioti-30207488.html
20. Reynolds L, McKee M. Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy, 2009, 90(1):32-36
21. Bi P, Tong S, Parton KA. Family self-medication and antibiotics abuse for children and juveniles in a Chinese city. Soc Sci Med, 2000, 50(10):1445-1450
22. Ramanan Laxminarayan AMDH. Extending the cure: policy responses to the growing threat of antibiotic resistance. Washington, DC 20036-1400 USA: 2007
23. Ministry of Health in China. Interim provisions on the administration of hospital pharmacy. 2002. http://www.moh.gov.cn/mohyzs/s3577/200804/18787.shtml (Chinese)
24. Xiao Y, Li L. Legislation of clinical antibiotic use in China. Lancet Infect Dis, 2013, 13(3):189-191
25. Yang L, Liu C, Ferrier JA, et al. The impact of the National Essential Medicines Policy on prescribing behaviours in primary care facilities in Hubei province of China. Health Policy Plan, 2012
26. Ministry of Health in China. Notification for the special campaign of antibiotics rational use in hospitals. 2012. http://www.moh.gov.cn/mohyzs/s3586/ 201203/54251.shtml (Chinese)
27. Regev-Yochay G, Raz M, Dagan R, et al. Reduction in antibiotic use following a cluster randomized controlled multifaceted intervention: the Israeli judicious antibiotic prescription study. Clin Infect Dis, 2011, 53(1):33-41
28. Kern WV, de With K, Nink K, et al. Regional variation in outpatient antibiotic prescribing in Germany. Infection, 2006, 34(5):269-273
29. Filippini M, Masiero G, Moschetti K. Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Health Policy, 2006, 78(1):77-92
30. National Bureau of Statistics in China. The Divide of Regions According to Economic Development in China. 2012. http://www.stats.gov.cn/tjzs/t20110613- 402731597.htm. (Chinese)
31. National Bureau of Statistics in China. Division Method of Regions. 2011. http://www.stats.gov.cn/tjzs/t20110613-402731597.htm. (Chinese)
32. Antachopoulos C, Dotis J, Pentsioglou V. Development of a paediatric daily defined dose system for the measurement of antibiotic consumption in paediatric units. 14th European Congress of Clinical Microbiology and Infectious Diseases. Prague, Czech Republic: 2004
33. Kern WV, de With K, Steib-Bauert M, et al. Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001-2002. Infection, 2005, 33(5-6):333-339
34. De WK, Steib-Bauert M, Straach P, et al. Is there significant regional variation in hospital antibiotic consumption in Germany? Infection, 2006, 34(5):274-277
35. Piovani D, Clavenna A, Cartabia M, et al. The regional profile of antibiotic prescriptions in Italian outpatient children. Eur J Clin Pharmacol, 2012, 68(6):997-1005
36. Zhang W, Shen X, Bergman U, et al. Drug utilisation 90% (DU90%) profiles of antibiotics in five Chinese children's hospitals (2002-2006). Int J Antimicrob Agents, 2008, 32(3):250-255
37. Ceyhan M, Yildirim I, Ecevit C, et al. Inappropriate antimicrobial use in Turkish pediatric hospitals: a multicenter point prevalence survey. Int J Infect Dis, 2010, 14(1): e55-e61
38. Ashiru-Oredope D, Sharland M, Charani E, et al. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart - Then Focus. J Antimicrob Chemother, 2012, 67(Suppl 1):i51-i63
39. Low M, Nitzan O, Bitterman H, et al. Trends in outpatient antibiotic use in Israel during the years 2000-2010: setting targets for an intervention. Infection, 2013, 41(2): 401-407
40. Cairns KA, Jenney AW, Abbott IJ, et al. Prescribing trends before and after implementation of an antimicrobial stewardship program. Med J Aust, 2013, 198(5): 262-266
41. Dumartin C, Rogues AM, Amadeo B, et al. Antibiotic stewardship programmes: legal framework and structure and process indicator in Southwestern French hospitals, 2005-2008. J Hosp Infect, 2011, 77(2):123-128
42. Hadi U, Keuter M, van Asten H, et al. Optimizing antibiotic usage in adults admitted with fever by a multifaceted intervention in an Indonesian governmental hospital. Trop Med Int Health, 2008, 13(7):888-899
43. Wilf-Miron R, Ron N, Ishai S, et al. Reducing the volume of antibiotic prescriptions: a peer group intervention among physicians serving a community with special ethnic characteristics. J Manag Care Pharm, 2012, 18(4): 324-328
44. Elseviers MM, Ferech M, Vander SR, et al. Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf, 2007, 16(1):115-123
45. Dumartin C, L'Heriteau F, Pefau M, et al. Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007. J Antimicrob Chemother, 2010, 65(9):2028-2036
46. Grau S, Fondevilla E, Mojal S, et al. Antibiotic consumption at 46 VINCat hospitals from 2007 to 2009, stratified by hospital size and clinical services. Enferm Infecc Microbiol Clin, 2012, 30(Suppl 3):43-51
47. D'Alerte R. Surveillance de la consommation des antibiotiques. Institut de veille sanitaire, 2010
48. Sumpradit N, Chongtrakul P, Anuwong K, et al. Antibiotics Smart Use: a workable model for promoting the rational use of medicines in Thailand. Bull World Health Organ, 2012, 90(12):905-913
49. Stockley JM. European Antibiotic Awareness Day 2012: getting smart about antibiotics, a public-professional partnership. J Infect, 2012, 65(5):377-379
50. Currie J, Lin W, Zhang W. Patient knowledge and antibiotic abuse: Evidence from an audit study in China. J Health Econ, 2011, 30(5):933-949
51. Goossens H, Ferech M, Vander SR, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet, 2005, 365(9459): 579-587
52. Kuster SP, Ruef C, Bollinger AK, et al. Correlation between case mix index and antibiotic use in hospitals. J Antimicrob Chemother, 2008, 62(4):837-842
53. Sabath LD, Notto DA. Analysis of factors influencing antibiotic usage in hospitals. Prog Clin Biol Res, 1979, 35:65-74